Simon Quick Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,102
Closed -$276K 286
2022
Q4
$276K Hold
2,102
0.03% 187
2022
Q3
$246K Hold
2,102
0.03% 166
2022
Q2
$276K Sell
2,102
-257
-11% -$30.5K 0.04% 142
2022
Q1
$307K Buy
2,359
+473
+25% +$61.6K 0.09% 83
2021
Q4
$288K Buy
1,886
+913
+94% +$141K 0.08% 94
2021
Q3
$157K Hold
973
0.04% 135
2021
Q2
$159K Sell
973
-114
-10% -$17.6K 0.04% 119
2021
Q1
$163K Sell
1,087
-28
-3% -$4.45K 0.05% 113
2020
Q4
$169K Buy
1,115
+200
+22% +$28.6K 0.05% 116
2020
Q3
$124K Hold
915
0.04% 117
2020
Q2
$125K Buy
915
+606
+196% +$77.3K 0.05% 109
2020
Q1
$33K Buy
309
+81
+36% +$9.33K 0.01% 236
2019
Q4
$27K Hold
228
0.01% 300
2019
Q3
$23K Sell
228
-9
-4% -$942 0.01% 231
2019
Q2
$25.9K Buy
237
+9
+4% +$957 0.01% 162
2019
Q1
$25K Hold
228
0.01% 285
2018
Q4
$22K Hold
228
0.01% 245
2018
Q3
$28K Hold
228
0.01% 208
2018
Q2
$25K Hold
228
0.01% 234
2018
Q1
$24K Sell
228
-30
-12% -$3.33K 0.01% 206
2017
Q4
$29K Sell
258
-693
-73% -$74.1K 0.01% 279
2017
Q3
$106K Hold
951
0.04% 187
2017
Q2
$98K Buy
951
+723
+317% +$71.2K 0.06% 92
2017
Q1
$22K Buy
+228
New +$21.8K 0.01% 206

Other funds holding IBB

Simon Quick Advisors's IBB Position: Q1 2023 in Review

Simon Quick Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 2,102 shares — an estimated $276K sold.

Simon Quick Advisors first reported a position in IBB in Q1 2017 and held it in 24 quarters. The position peaked at $307K in Q1 2022. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

  • Simon Quick Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • Simon Quick Advisors sold 2,102 iShares Biotechnology ETF shares in Q1 2023, an estimated $276K.
  • Simon Quick Advisors first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 24 quarters.
  • Simon Quick Advisors's iShares Biotechnology ETF position peaked at $307K in Q1 2022.
  • 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Simon Quick Advisors's 13F filing for Q1 2023, filed 15 May 2023.